The Center for Technology Licensing (CTL) is Cornell University's technology transfer office. We manage technology for Cornell's Ithaca campus, Weill Cornell Medicine, Cornell Tech, and Cornell AgriTech in Geneva.

CTL@WCM Special Panel Series

 

The Special Panel is a series of webinars where panelists, experts in different topics, will address the challenges and opportunities of bringing medical technology to commercialization.

 

CTL@WCM Special Panel on Health Equity

Tuesday, October 11th at 12PM ET

 

On the occasion of the diversity month, Weill Cornell Medicine Enterprise Innovation’s CTL@WCM is addressing disparities in health and health care affecting underrepresented groups.

 

Gender, ethnoracial background, income, housing, and geographic location, etc. are just some of factors that influence health and well-being. People of color and other marginalized groups are the most impacted by healthcare inequity, and they experience higher rates of illness. Racial disparities, particularly, is estimated to cost $93 billion in excess medical care.

 

In a special panel, experts from academia, industry, government, and investment will provide insights on the state of healthcare, will discuss solutions to improve the conditions that drive health outcomes (equitable access to care, diversification of clinical trials, etc.), and will describe existing programs that can sustainably address health disparities, with a commercialization and investment lens.

 

Panelists

• Pierre R. Theodore, MD, Vice President, Global Public Health, J&J
• Rachel Rubin ‘07, Vice President, Investments and Programs, Roivant Social Ventures
• J’Vanay Santos-Fabian, MBA candidate, Co-Founder & Chief Executive Officer, My LÚA

 

Moderated by Lisa Placanica, Senior Managing Director, CTL @ WCM

 

Register here.

 


CTL@WCM Special Panel on Drug Repurposing

Tuesday, May 24th at 1 pm (EST)

 

Can you teach an old drug new tricks? Recent successes in repositioning existing drugs – from esketamine for treatment-resistant depression to remdesivir – originally developed to treat hepatitis C, tested for Ebola before being approved as a treatment for COVID 19 – point to potential upsides. The challenges, however, are many: from challenging IP prospects to skeptical investors. We have assembled an expert panel to discuss with us the enticing shortcuts repurposing may offer, the pitfalls it brings and how to develop strategies to overcome them.

 

Join us at the second virtual CTL@WCM Special Panel, where innovators, IP experts, and regulators gather to assess the landscape and talk about the opportunities.

 

Featured panelists:
Dr. Bruce Bloom, Chief Collaboration Officer, Healx
Eyal Barash, J.D., M.S, Founder Barash Law
Valentyna Chebanova, Sr. Manager of Business Development at Tarsus Pharmaceuticals

Moderated by Lisa Placanica, Senior Managing Director, Center for Technology Licensing at Weill Cornell Medicine

 

Watch the recording here.


CTL@WCM Special Panel on Women’s Health

March 17 from noon – 1:00 p.m. (EST)

 

From reproductive health menopause to mental health, more attention is being paid to women’s health issues as they are becoming less taboo. As of 2021, the women’s health segment accounts for only 4% of R&D funding and only 1.4% of capital invested in healthcare [1]; however, it is one of the fastest-growing segments in the healthcare industry. The field is mainly driven by innovation in digital health and surgical innovations.

 

In a special panel, CTL@WCM will address the opportunities in the field with the lens of commercialization and venture creation. Our guest panelists will provide insight as we explore the trends in women’s health, the emergence of women-led companies, and the role of women founders.

 

Panelists

  • Tamatha Fenster, Assistant Professor of Clinical Obstetrics and Gynecology, Obstetrics and Gynecology, Weill Cornell Medicine
  • Sabrina Johnson, President and CEO, Daré bioscience
  • Vrunda Desai, Global Head of Medical Affairs, CooperSurgical, and Assistant Professor, Adjunct, in Obstetrics, Gynecology and Reproductive Sciences at Yale University School of Medicine.
  • Maria Velissaris, Founding Partner at SteelSky Ventures

 

[1] FemTech Industry 2021: Landscape Overview

 

Watch the recording here.